A potential new candidate uses uracil to combat this cancer treatment side effect.
Michael D. Becker
Advertisement
Articles by Michael D. Becker
Advertisement
Latest Updated Articles
- Tech Sectors: Biotechnology: The Treatment of Palmar-plantar Erythrodysesthesia
Published: September 18th 2008 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5